Pharmacogenetics and individualizing drug treatment during pregnancy

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Pharmacogenetics as a tool to aid clinicians implement individualized pharmacotherapy is utilized in some areas of medicine. Pharmacogenetics in pregnancy is still a developing field. However, there are several areas of obstetric therapeutics where data are emerging that give glimpses into future therapeutic possibilities. These include opioid pain management, antihypertensive therapy, antidepressant medications, preterm labor tocolytics, antenatal corticosteroids and drugs for nausea and vomiting of pregnancy, to name a few. More data are needed to populate the therapeutic models and to truly determine if pharmacogenetics will aid in individualizing pharmacotherapy in pregnancy. The objective of this review is to summarize current data and highlight research needs.

Original languageEnglish (US)
Pages (from-to)69-78
Number of pages10
JournalPharmacogenomics
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Pharmacogenetics
Pregnancy
Pharmaceutical Preparations
Tocolytic Agents
Drug Therapy
Premature Obstetric Labor
Pain Management
Therapeutics
Nausea
Opioid Analgesics
Antihypertensive Agents
Antidepressive Agents
Obstetrics
Names
Vomiting
Adrenal Cortex Hormones
Medicine
Research

Keywords

  • Pharmacogenetics
  • Pregnancy
  • Therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Genetics
  • Molecular Medicine

Cite this

Pharmacogenetics and individualizing drug treatment during pregnancy. / Haas, David M.

In: Pharmacogenomics, Vol. 15, No. 1, 01.01.2014, p. 69-78.

Research output: Contribution to journalReview article

@article{1ec2eecc529248e1a4269540ac96af4c,
title = "Pharmacogenetics and individualizing drug treatment during pregnancy",
abstract = "Pharmacogenetics as a tool to aid clinicians implement individualized pharmacotherapy is utilized in some areas of medicine. Pharmacogenetics in pregnancy is still a developing field. However, there are several areas of obstetric therapeutics where data are emerging that give glimpses into future therapeutic possibilities. These include opioid pain management, antihypertensive therapy, antidepressant medications, preterm labor tocolytics, antenatal corticosteroids and drugs for nausea and vomiting of pregnancy, to name a few. More data are needed to populate the therapeutic models and to truly determine if pharmacogenetics will aid in individualizing pharmacotherapy in pregnancy. The objective of this review is to summarize current data and highlight research needs.",
keywords = "Pharmacogenetics, Pregnancy, Therapeutics",
author = "Haas, {David M.}",
year = "2014",
month = "1",
day = "1",
doi = "10.2217/pgs.13.228",
language = "English (US)",
volume = "15",
pages = "69--78",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "1",

}

TY - JOUR

T1 - Pharmacogenetics and individualizing drug treatment during pregnancy

AU - Haas, David M.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Pharmacogenetics as a tool to aid clinicians implement individualized pharmacotherapy is utilized in some areas of medicine. Pharmacogenetics in pregnancy is still a developing field. However, there are several areas of obstetric therapeutics where data are emerging that give glimpses into future therapeutic possibilities. These include opioid pain management, antihypertensive therapy, antidepressant medications, preterm labor tocolytics, antenatal corticosteroids and drugs for nausea and vomiting of pregnancy, to name a few. More data are needed to populate the therapeutic models and to truly determine if pharmacogenetics will aid in individualizing pharmacotherapy in pregnancy. The objective of this review is to summarize current data and highlight research needs.

AB - Pharmacogenetics as a tool to aid clinicians implement individualized pharmacotherapy is utilized in some areas of medicine. Pharmacogenetics in pregnancy is still a developing field. However, there are several areas of obstetric therapeutics where data are emerging that give glimpses into future therapeutic possibilities. These include opioid pain management, antihypertensive therapy, antidepressant medications, preterm labor tocolytics, antenatal corticosteroids and drugs for nausea and vomiting of pregnancy, to name a few. More data are needed to populate the therapeutic models and to truly determine if pharmacogenetics will aid in individualizing pharmacotherapy in pregnancy. The objective of this review is to summarize current data and highlight research needs.

KW - Pharmacogenetics

KW - Pregnancy

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=84890483013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890483013&partnerID=8YFLogxK

U2 - 10.2217/pgs.13.228

DO - 10.2217/pgs.13.228

M3 - Review article

C2 - 24329192

AN - SCOPUS:84890483013

VL - 15

SP - 69

EP - 78

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 1

ER -